The Fosun and Hidea-backed stroke therapy technology developer has raised an eight-digit sum that will help advance its product pipeline.
Stroke Care, a China-based stroke therapy product developer backed by conglomerate Fosun and outboard motor manufacturer Hidea, has secured an eight-figure dollar amount of series C funding, DealStreetAsia reported yesterday.
Healthcare investment firm Sherpa Healthcare Partners and private equity firm Lyfe Capital supplied the funding, two months after an investment of undisclosed size by SDIC Unity Capital, part of the Chinese state-owned State Development and Investment Corporation.
Founded in 2016, Stroke Care is working on technology that will assist in…
